Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy clinical trial (NCT06747845). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of niraparib and ipilimumab compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy clinical trial (NCT06747845). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of with this new treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy clinical trial (NCT06747845). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy clinical trial (NCT06747845). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the logistics of undergoing biopsies during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy clinical trial (NCT06747845). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my cancer progresses while I am in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy clinical trial (NCT06747845). Contact the study team or your healthcare provider for specific answers.

What this study is about